About

​Chris is the Global ABAC Director at GSK, where he plays a leading role in developing and embedding the ABAC programme across the business. His areas of focus include policy and procedure design, management of conflicts of interest, development of impactful ABAC training, and third-party risk management. Chris provides strategic and operational guidance to senior stakeholders on ABAC and economic crime compliance, and serves as the lead compliance SME for GSK’s response to the UK’s Failure to Prevent Fraud offence.

Prior to joining GSK, Chris worked in Deloitte’s Strategic, Regulatory and Operational Risk team, where he led complex client engagements within the pharmaceutical sector. His experience includes compliance framework reviews, third-party risk management implementations, and internal audits. Outside of his day-to-day responsibilities, Chris is passionate about promoting ethical business practices and actively supports Transparency International UK’s Business Integrity Forum.